Safety and Effectiveness of Amphotericin B Deoxycholate for the Treatment of Visceral Leishmaniasis in Uganda.
AffiliationMédecins Sans Frontières, Swiss Section, Rue de Lausanne 78, 1202 Geneva, Switzerland. email@example.com
MetadataShow full item record
AbstractBetween September 2003 and April 2004, the supply of antimonial drugs to Amudat Hospital, in north-eastern Uganda, was interrupted and all cases of visceral leishmaniasis presenting at the hospital could only be treated with amphotericin B deoxycholate (AmB). This allowed the safety and effectiveness of the AmB to be evaluated, in comparison with an historical cohort of patients treated, at the same hospital, with meglumine antimoniate (Sb(V)). Demographic and clinical data were collected before and after treatment. Adverse effects were recorded passively in all the subjects, and actively, using a standardized questionnaire, in a sub-group of the patients given AmB. The in hospital case-fatality 'rates' were 4.8% [95% confidence interval (CI) = 2.4%-8.8%] among the 210 patients treated with AmB and 3.7% (CI = 1.4%-7.9%) among the 161 patients treated with Sb(V) (P>0.20). Adverse effects requiring treatment interruption were rare in both cohorts. Treatment failures (i.e. non-responses or relapses) were observed in 2.9% (CI = 1.2%-6.4%) of the patients treated with AmB and 1.2% (CI = 0.1%-4.4%) of the patients treated with Sb(V) (P>0.20). For the treatment of visceral leishmaniasis in Uganda, AmB therefore had a similar effectiveness and safety profile to that of meglumine antimoniate.
- Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
- Authors: Silveira LJ, Rocha TJ, Ribeiro SA, Pedrosa CM
- Issue date: 2015 Jan-Feb
- Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
- Authors: Laguna F, López-Vélez R, Pulido F, Salas A, Torre-Cisneros J, Torres E, Medrano FJ, Sanz J, Picó G, Gómez-Rodrigo J, Pasquau J, Alvar J
- Issue date: 1999 Jun 18
- Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
- Authors: Borges MM, Pranchevicius MC, Noronha EF, Romero GA, Carranza-Tamayo CO
- Issue date: 2017 Jan-Feb
- Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
- Authors: Cascio A, Colomba C, Antinori S, Orobello M, Paterson D, Titone L
- Issue date: 2002 Apr
- [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
- Authors: Gradoni L, Gramiccia M, Scalone A
- Issue date: 2004 Jun